220 related articles for article (PubMed ID: 17325276)
21. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
22. PIN1 promoter polymorphisms are associated with Alzheimer's disease.
Segat L; Pontillo A; Annoni G; Trabattoni D; Vergani C; Clerici M; Arosio B; Crovella S
Neurobiol Aging; 2007 Jan; 28(1):69-74. PubMed ID: 16384626
[TBL] [Abstract][Full Text] [Related]
23. Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis.
Rainero I; Bo M; Ferrero M; Valfrè W; Vaula G; Pinessi L
Neurobiol Aging; 2004; 25(10):1293-8. PubMed ID: 15465625
[TBL] [Abstract][Full Text] [Related]
24. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease.
Bettens K; Brouwers N; Engelborghs S; Van Miegroet H; De Deyn PP; Theuns J; Sleegers K; Van Broeckhoven C
Hum Mutat; 2009 Aug; 30(8):1207-13. PubMed ID: 19462468
[TBL] [Abstract][Full Text] [Related]
25. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; van der Zee J; Pickut BA; Van den Broeck M; Mattheijssens M; Peeters K; Schymkowitz J; Rousseau F; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C
Neurology; 2008 Aug; 71(9):656-64. PubMed ID: 18565828
[TBL] [Abstract][Full Text] [Related]
26. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
Gault J; Sain S; Hu LJ; Awad IA
Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691
[TBL] [Abstract][Full Text] [Related]
27. SNPs and haplotypes in the S100B gene reveal association with schizophrenia.
Liu J; Shi Y; Tang J; Guo T; Li X; Yang Y; Chen Q; Zhao X; He G; Feng G; Gu N; Zhu S; Liu H; He L
Biochem Biophys Res Commun; 2005 Mar; 328(1):335-41. PubMed ID: 15670788
[TBL] [Abstract][Full Text] [Related]
28. Functional characterization of amyloid beta precursor protein regulatory elements: rationale for the identification of genetic polymorphism.
Lahiri DK
Ann N Y Acad Sci; 2004 Dec; 1030():282-8. PubMed ID: 15659808
[TBL] [Abstract][Full Text] [Related]
29. Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease.
Riemenschneider M; Mahmoodzadeh S; Eisele T; Klopp N; Schwarz S; Wagenpfeil S; Diehl J; Mueller U; Foerstl H; Illig T; Kurz A
Neurobiol Aging; 2004; 25(10):1305-8. PubMed ID: 15465627
[TBL] [Abstract][Full Text] [Related]
30. No association was found between a functional SNP in ZDHHC8 and schizophrenia in a Japanese case-control population.
Saito S; Ikeda M; Iwata N; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Takahashi N; Inada T; Ozaki N
Neurosci Lett; 2005 Feb; 374(1):21-4. PubMed ID: 15631889
[TBL] [Abstract][Full Text] [Related]
31. A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome.
Wang Y; Wu X; Cao Y; Yi L; Chen J
Fertil Steril; 2006 Jul; 86(1):223-6. PubMed ID: 16764871
[TBL] [Abstract][Full Text] [Related]
32. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
33. Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease.
Lahiri DK; Ge YW; Maloney B; Wavrant-De Vrièze F; Hardy J
Neurobiol Aging; 2005; 26(10):1329-41. PubMed ID: 16243604
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of betaglycan/TGF-betaRIII in premature ovarian failure.
Chand AL; Robertson DM; Shelling AN; Harrison CA
Fertil Steril; 2007 Jan; 87(1):210-2. PubMed ID: 17084394
[TBL] [Abstract][Full Text] [Related]
35. UDP-glucuronosyltransferase 1A7 polymorphisms are associated with liver cirrhosis.
Tang KS; Lee CM; Teng HC; Huang MJ; Huang CS
Biochem Biophys Res Commun; 2008 Feb; 366(3):643-8. PubMed ID: 18054330
[TBL] [Abstract][Full Text] [Related]
36. A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort.
Baumber L; Sjöstrand C; Leone M; Harty H; Bussone G; Hillert J; Trembath RC; Russell MB
Neurology; 2006 Jun; 66(12):1888-93. PubMed ID: 16801656
[TBL] [Abstract][Full Text] [Related]
37. Genetic diversity in german and European populations: looking for substructures and genetic patterns.
Lamina C; Steffens M; Mueller J; Lohmussaar E; Meitinger T; Wichmann HE
Gesundheitswesen; 2005 Aug; 67 Suppl 1():S127-31. PubMed ID: 16032530
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's.
Bullido MJ; Ramos MC; Ruiz-Gómez A; Tutor AS; Sastre I; Frank A; Coria F; Gil P; Mayor F; Valdivieso F
Neurobiol Aging; 2004 Aug; 25(7):853-9. PubMed ID: 15212839
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetics of Alzheimer's disease: an update.
Brouwers N; Sleegers K; Van Broeckhoven C
Ann Med; 2008; 40(8):562-83. PubMed ID: 18608129
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
